Get the Stockscreener App
173.47
0.85%
1.40
Davita Inc stock is traded at $173.47, with a volume of 200.28K.
It is up +0.85% in the last 24 hours and up +13.65% over the past month.
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,000 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives about two thirds of U.S. sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
See More
Previous Close:
$172.07
Open:
$171.14
24h Volume:
200.28K
Relative Volume:
0.31
Market Cap:
$15.09B
Revenue:
$12.67B
Net Income/Loss:
$827.68M
P/E Ratio:
18.71
EPS:
9.27
Net Cash Flow:
$1.42B
1W Performance:
-1.52%
1M Performance:
+13.65%
6M Performance:
+29.52%
1Y Performance:
+55.48%
1-Day Range:
$170.81
$174.59
1-Week Range:
$169.36
$178.47
52-Week Range:
$108.76
$179.60
Davita Inc Stock (DVA) Company Profile
Name
Davita Inc
Sector
Industry
Phone
310-536-2668
Address
2000 16TH STREET, DENVER, CO
Compare DVA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DVA
Davita Inc
|
173.52 | 15.09B | 12.67B | 827.68M | 1.42B | 9.27 |
|
HCA
Hca Healthcare Inc
|
322.88 | 82.20B | 70.60B | 5.76B | 5.64B | 21.97 |
|
FMS
Fresenius Medical Care Ag Adr
|
24.20 | 14.26B | 20.87B | 715.14M | 1.67B | 1.2209 |
|
THC
Tenet Healthcare Corp
|
140.05 | 13.66B | 20.97B | 3.13B | 2.39B | 31.21 |
|
UHS
Universal Health Services Inc
|
187.44 | 12.43B | 15.42B | 1.03B | 956.84M | 15.02 |
Davita Inc Stock (DVA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-06-24 | Initiated | Barclays | Equal Weight |
| Aug-07-23 | Upgrade | UBS | Neutral → Buy |
| Nov-01-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Oct-31-22 | Downgrade | UBS | Buy → Neutral |
| Aug-19-22 | Resumed | UBS | Buy |
| Jun-21-22 | Reiterated | BofA Securities | Underperform |
| Sep-10-21 | Initiated | Cowen | Market Perform |
| Aug-12-21 | Downgrade | Barclays | Overweight → Equal Weight |
| Mar-26-21 | Downgrade | BofA Securities | Neutral → Underperform |
| Jan-05-21 | Downgrade | BofA Securities | Buy → Neutral |
| Jan-24-20 | Upgrade | Goldman | Neutral → Buy |
| Nov-07-19 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Oct-25-19 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Sep-11-19 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jul-26-19 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Jan-08-19 | Upgrade | UBS | Sell → Neutral |
| Jan-03-19 | Initiated | Deutsche Bank | Buy |
| Dec-14-18 | Initiated | Barclays | Overweight |
| Nov-28-18 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Nov-16-18 | Initiated | UBS | Sell |
| Nov-08-18 | Downgrade | Raymond James | Strong Buy → Mkt Perform |
| Sep-13-18 | Upgrade | JP Morgan | Underweight → Neutral |
| Jan-04-18 | Upgrade | BofA/Merrill | Neutral → Buy |
| Dec-12-17 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Dec-11-17 | Upgrade | Citigroup | Neutral → Buy |
| Dec-07-17 | Upgrade | Raymond James | Outperform → Strong Buy |
| Nov-08-17 | Reiterated | RBC Capital Mkts | Sector Perform |
| Oct-09-17 | Downgrade | JP Morgan | Neutral → Underweight |
| Jun-26-17 | Downgrade | Jefferies | Buy → Hold |
| Dec-13-16 | Downgrade | Robert W. Baird | Outperform → Neutral |
View All
Davita Inc Stock (DVA) Latest News
Tour DaVita's Net-Zero Dialysis Center -February 07, 2025 at 10:30 am EST - Marketscreener.com
DaVita Inc. (NYSE:DVA) Shares Sold by GHP Investment Advisors Inc. - MarketBeat
Robeco Institutional Asset Management B.V. Sells 24,707 Shares of DaVita Inc. (NYSE:DVA) - MarketBeat
DaVita (DVA) Projected to Post Quarterly Earnings on Tuesday - MarketBeat
Mediolanum International Funds Ltd Buys New Stake in DaVita Inc. (NYSE:DVA) - MarketBeat
abrdn plc Has $27.29 Million Stock Holdings in DaVita Inc. (NYSE:DVA) - MarketBeat
DaVita Celebrates Kidney Care Community Achievements in Year One of Largest-Ever Value-Based Care Program - Yahoo Finance
DaVita: Momentum Could Fade Given High Valuation - Seeking Alpha
DaVita Inc. (NYSE:DVA) Short Interest Up 9.2% in January - MarketBeat
DaVita HealthCare (DVA) Increases Yet Falls Behind Market: What Investors Need to Know - Yahoo Finance
DaVita (NYSE:DVA) Reaches New 1-Year HighTime to Buy? - MarketBeat
SteelPeak Wealth LLC Makes New $1.05 Million Investment in DaVita Inc. (NYSE:DVA) - MarketBeat
Inlet Private Wealth LLC Sells 2,800 Shares of DaVita Inc. (NYSE:DVA) - MarketBeat
Forsta AP Fonden Has $3.01 Million Position in DaVita Inc. (NYSE:DVA) - MarketBeat
3 No-Brainer Warren Buffett Stocks to Buy Right Now - The Motley Fool
Patton Fund Management Inc. Reduces Position in DaVita Inc. (NYSE:DVA) - MarketBeat
DaVita (NYSE:DVA) Hits New 1-Year HighWhat's Next? - MarketBeat
DaVita stock soars to all-time high of $179 amid robust growth - Investing.com Australia
DaVita (NYSE:DVA) jumps 3.5% this week, though earnings growth is still tracking behind five-year shareholder returns - Yahoo Finance
KBC Group NV Boosts Position in DaVita Inc. (NYSE:DVA) - MarketBeat
Is DaVita Inc. (DVA) Among Warren Buffett’s Longest-Held Stocks? - Insider Monkey
DaVita Inc. stock outperforms competitors on strong trading day - MarketWatch
DaVita Earnings Preview: What to Expect - MSN
Warren Buffett’s 10 Longest-Held Stocks - Insider Monkey
DaVita Inc. Schedules 4th Quarter 2024 Investor Conference Call - The Malaysian Reserve
Does DaVita (NYSE:DVA) Have A Healthy Balance Sheet? - Simply Wall St
DaVita Inc. (DVA): Enhancing Kidney Care Through Advanced AI Models - Insider Monkey
DaVita HealthCare (DVA) Ascends While Market Falls: Some Facts to Note - Yahoo Finance
DaVita HealthCare (DVA) Upgraded to Strong Buy: Here's Why - Yahoo Finance
DaVita stock soars to all-time high of $169.54 amid robust growth - MSN
Allen learns about dialysis legislation - Statesboro Herald
Bernstein Adjusts Price Target on DaVita to $184 From $161, Maintains Market Perform Rating - Marketscreener.com
Zacks Investment Ideas feature highlights: Nvidia, Vertiv, Vistra and DaVita - Yahoo Finance
DaVita (NYSE:DVA) Hits New 12-Month HighStill a Buy? - MarketBeat
First Citizens Bank & Trust Co. Sells 1,907 Shares of DaVita Inc. (NYSE:DVA) - MarketBeat
Nisa Investment Advisors LLC Has $6.06 Million Stock Position in DaVita Inc. (NYSE:DVA) - MarketBeat
DaVita (NYSE:DVA) Sets New 52-Week HighShould You Buy? - MarketBeat
DaVita HealthCare (DVA) Exceeds Market Returns: Some Facts to Consider - Yahoo Finance
DaVita (NYSE:DVA) Reaches New 12-Month HighHere's What Happened - MarketBeat
DaVita stock soars to all-time high of $169.54 amid robust growth By Investing.com - Investing.com South Africa
Davita Inc Stock (DVA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.37%
0.19%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):